What does Ori Biotech do?

Ori Biotech is a cell and gene therapy manufacturing technology company founded in 2015 by Dr. Farlan Veraitch and Prof. Chris Mason. With locations in London, Philadelphia, and New Jersey, Ori develops proprietary manufacturing platforms aimed at automating and standardizing the production of cell and gene therapies. Their mission is to enhance patient access to these therapies by addressing manufacturing challenges such as high costs and variability. The company's main offering is the IRO® platform, which integrates automation, data analytics, and a benchtop cell processing system to streamline the manufacturing process. This platform supports various therapy types, initially focusing on cell therapies like CAR-T. Ori also launched the Lightspeed Early Access Program (LEAP) in 2022, providing select partners with pre-launch access to their technology. Ori Biotech has formed partnerships with organizations like Achilles Therapeutics and Hitachi Chemical, targeting therapy developers and contract manufacturers as key customer segments.